Search

Your search keyword '"Sid E. O'Bryant"' showing total 77 results
Start Over Author "Sid E. O'Bryant" Journal alzheimer's & dementia
77 results on '"Sid E. O'Bryant"'

7. Type 2 diabetes and cortical thickness in older Mexican Americans and non‐Hispanic Whites

Author

Meredith N Braskie, Nalini Hazra, Deydeep Kothapalli, HyungJin Cho, Jacob Lester, Jessica N Rogers, Raymond F. Palmer, Raul Vintimilla, Leigh Johnson, Kristine Yaffe, Arthur W. Toga, and Sid E. O'Bryant

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Neurology (clinical), Geriatrics and Gerontology
Published
2022

11. A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community‐dwelling Mexican Americans and non‐Hispanic Whites: A method for increasing representation of diverse populations in clinical research

Author

Robert A. Rissman, Fan Zhang, Mark Mapstone, Arthur W. Toga, David C. Mason, Hable study team, Michelle M. Mielke, Kristine Yaffe, Meredith N. Braskie, Melissa Petersen, Leigh Johnson, Robert Barber PhD, Sid E. O'Bryant, and James Hall

Subjects
Male, Proteomics, Gerontology, Epidemiology, Ethnic group, Disease, Neuropsychological Tests, White People, 03 medical and health sciences, Cellular and Molecular Neuroscience, 0302 clinical medicine, Developmental Neuroscience, Alzheimer Disease, Mexican Americans, Magnetic resonance imaging of the brain, medicine, Humans, Mass Screening, Aging brain, Dementia, Cognitive Dysfunction, 030212 general & internal medicine, Aged, medicine.diagnostic_test, business.industry, Patient Selection, Health Policy, Blood Screening, medicine.disease, Non-Hispanic whites, Psychiatry and Mental health, Clinical research, Female, Independent Living, Neurology (clinical), Geriatrics and Gerontology, business, Biomarkers, 030217 neurology & neurosurgery
Abstract

Introduction Representation of Mexican Americans in Alzheimer's disease (AD) clinical research has been extremely poor. Methods Data were examined from the ongoing community-based, multi-ethnic Health & Aging Brain among Latino Elders (HABLE) study. Participants underwent functional exams, clinical labs, neuropsychological testing, and 3T magnetic resonance imaging of the brain. Fasting proteomic markers were examined for predicting mild cognitive impairment (MCI) and AD using support vector machine models. Results Data were examined from n = 1649 participants (Mexican American n = 866; non-Hispanic White n = 783). Proteomic profiles were highly accurate in detecting MCI (area under the curve [AUC] = 0.91) and dementia (AUC = 0.95). The proteomic profiles varied significantly between ethnic groups and disease state. Negative predictive value was excellent for ruling out MCI and dementia across ethnic groups. Discussion A blood-based screening tool can serve as a method for increasing access to state-of-the-art AD clinical research by bridging between community-based and clinic-based settings.

Published
2021

12. Using the Framingham Cardiovascular Disease Risk Score to predict cognitive performance in cognitively normal non‐hispanic whites and Mexican American elders

Author

Kishore Balasubramanian, Raul Vintimilla, Sid E. O'Bryant, Leigh A. Johnson, and James Hall

Subjects
Gerontology, Framingham Risk Score, Epidemiology, business.industry, Health Policy, Neuropsychology, Mexican americans, medicine.disease, Non-Hispanic whites, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Disease risk, Medicine, Dementia, Neurology (clinical), Effects of sleep deprivation on cognitive performance, Geriatrics and Gerontology, business
Published
2020

13. Anterolateral entorhinal cortical thinning as a biomarker for Alzheimer’s disease in Down syndrome

Author

Dana Nguyen, Florence Lai, Michael J. Phelan, Anna Smith, H. Diana Rosas, Eric Doran, Christy Hom, Adam M. Brickman, Nicholas J. Tustison, Nicole Schupf, John Janecek, Melissa Petersen, Ira T. Lott, David Keator, Michael A. Yassa, Wayne Silverman, Mithra Sathishkumar, and Sid E. O'Bryant

Subjects
Down syndrome, Pathology, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Cortical thinning, Disease, medicine.disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, medicine, Biomarker (medicine), Neurology (clinical), Geriatrics and Gerontology, business
Published
2020

14. Blood‐brain barrier dysfunction and perioperative neurocognitive disorders: Cognitive Recovery after Elective Surgery (CREATES) study design and methods

Author

Danny J.J. Wang, Sharon K. Inouye, Sid E. O'Bryant, William G. Cioffi, Geoffrey Tremont, Mark C. Kendall, Lori A. Daiello, Richard N. Jones, Gildasio S. De Oliveira, Jerrold L. Boxerman, and Brian R. Ott

Subjects
medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Cognition, Perioperative, Blood–brain barrier, Psychiatry and Mental health, Cellular and Molecular Neuroscience, medicine.anatomical_structure, Developmental Neuroscience, Neuroimaging, medicine, Neurology (clinical), Geriatrics and Gerontology, Elective surgery, business, Intensive care medicine, Neurocognitive
Published
2020

15. The role of co‐morbid hypertension and depression on cognitive and proteomic outcomes among Mexican Americans

Author

Sandra E. Davis, Stephanie Large, Leigh A. Johnson, Melissa Petersen, Marcela Davila, Sid E. O'Bryant, and James Hall

Subjects
medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Cognition, Mexican americans, Co morbid, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Medicine, Neurology (clinical), Geriatrics and Gerontology, business, Psychiatry, Depression (differential diagnoses)
Published
2020

16. Plasma biomarkers Aβ42, Aβ40, and tau in Down syndrome dementia

Author

Ira T. Lott, Nicole Schupf, H. Diana Rosas, Melissa Petersen, Joseph H. Lee, Deborah Pang, Sid E. O'Bryant, Min Suk Kang, Wayne Silverman, Howard Andrews, Sharon J. Krinsky-McHale, Lawrence S. Honig, and Florence Lai

Subjects
Oncology, medicine.medical_specialty, Down syndrome, Epidemiology, business.industry, Health Policy, medicine.disease, Plasma biomarkers, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Internal medicine, Medicine, Dementia, Neurology (clinical), Geriatrics and Gerontology, business
Published
2020

17. Level of plasma tau and depression, anxiety and worry in cognitively normal older adults

Author

Melissa Petersen, James Hall, Leigh A. Johnson, and Sid E. O'Bryant

Subjects
Epidemiology, business.industry, Health Policy, media_common.quotation_subject, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Medicine, Anxiety, Neurology (clinical), Geriatrics and Gerontology, Worry, medicine.symptom, business, Depression (differential diagnoses), Clinical psychology, media_common
Published
2020

18. Aerobic exercise effects on the peripheral plasma lipidome in mild cognitive impairment: The influence of prediabetes

Author

Amrita K. Cheema, Sid E. O'Bryant, Thomas J. Gross, Laura D. Baker, Carl W. Cotman, Mark A. Espeland, and Mark Mapstone

Subjects
medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Peripheral plasma, Lipidome, medicine.disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Internal medicine, medicine, Cardiology, Aerobic exercise, Neurology (clinical), Prediabetes, Geriatrics and Gerontology, business, Cognitive impairment
Published
2020

19. The relationship of a white matter hyperintensities rating scale and cognition among Mexican Americans

Author

Arthur W. Toga, Raul Vintimilla, Leigh A. Johnson, Kevin S. King, Meredith N. Braskie, Kristine Yaffe, James Hall, and Sid E. O'Bryant

Subjects
Epidemiology, Health Policy, Cognition, Mexican americans, Hyperintensity, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Neuroimaging, Rating scale, Neurology (clinical), Geriatrics and Gerontology, Psychology, Brain aging, Clinical psychology
Published
2020

20. Plasma neurofilament light chain (NFL) is differentially associated with neuropsychological test performance among non‐Hispanic whites and hispanic, Mexican Americans: A HABLE study

Author

Meredith N. Braskie, Arthur W. Toga, Kristine Yaffe, Leigh A. Johnson, Melissa Petersen, Kevin S. King, Sima Mozdbar, James Hall, and Sid E. O'Bryant

Subjects
medicine.diagnostic_test, Epidemiology, business.industry, Health Policy, Neurofilament light, Neuropsychological test, Mexican americans, Non-Hispanic whites, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Medicine, Neurology (clinical), Geriatrics and Gerontology, business, Demography
Published
2020

21. Anterolateral entorhinal cortical thinning as a biomarker for Alzheimer’s disease in Down syndrome

Author

Michael J. Phelan, Christy Hom, Ira T. Lott, Dana Nguyen, Anna Smith, H. Diana Rosas, Melissa Petersen, Florence Lai, Eric Doran, Mithra Sathishkumar, Wayne Silverman, John Janecek, Sid E. O'Bryant, David Keator, Michael A. Yassa, Adam M. Brickman, Nicholas J. Tustison, and Nicole Schupf

Subjects
Down syndrome, Epidemiology, business.industry, Health Policy, Early detection, Cortical thinning, Disease, medicine.disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Neuroimaging, medicine, Biomarker (medicine), Neurology (clinical), Geriatrics and Gerontology, business, Neuroscience
Published
2020

22. Elevated plasma neurofilament light (NfL) is associated with incident Alzheimer’s disease and accelerated cognitive decline in adults with Down syndrome

Author

Lam-Ha T. Dang, Sharon J. Krinsky-McHale, Warren B. Zigman, Wayne Silverman, Nicole Schupf, Deborah Pang, Sid E. O'Bryant, and Joseph H. Lee

Subjects
medicine.medical_specialty, Down syndrome, Epidemiology, business.industry, Health Policy, Neurofilament light, Disease, medicine.disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Endocrinology, Developmental Neuroscience, Internal medicine, medicine, Neurology (clinical), Geriatrics and Gerontology, Cognitive decline, business
Published
2020

23. P3‐330: THE RELATIONSHIP OF HYPERTENSION AND RELATED CARDIOVASCULAR RISK FACTORS TO EXECUTIVE FUNCTIONING IN MEXICAN AMERICANS

Author

Sid E. O'Bryant, Leigh A. Johnson, James Hall, and Raul Vintimilla

Subjects
Gerontology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, business.industry, Health Policy, Cardiovascular risk factors, Medicine, Neurology (clinical), Geriatrics and Gerontology, Mexican americans, business
Published
2018

24. F5‐01‐01: PROTEOMIC BIOMARKERS FOR DETECTING AND PREDICTING AD RISK AMONG ADULTS WITH DOWN SYNDROME

Author

Deborah Pang, Sid E. O'Bryant, Fan Zhang, Warren B. Zigman, Nicole Schupf, Wayne Silverman, Sharon J. Krinsky-McHale, and Joseph H. Lee

Subjects
0301 basic medicine, Oncology, Down syndrome, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, medicine.disease, 03 medical and health sciences, Psychiatry and Mental health, Cellular and Molecular Neuroscience, 030104 developmental biology, 0302 clinical medicine, Developmental Neuroscience, Internal medicine, medicine, Neurology (clinical), Geriatrics and Gerontology, business, 030217 neurology & neurosurgery
Published
2018

25. P3‐498: CHARACTERIZATION OF WORRY AND COGNITION IN MEXICAN AMERICAN WOMEN

Author

Stephanie Large, James Hall, Sid E. O'Bryant, Leigh A. Johnson, and Judith Rosemary O'Jile

Subjects
Epidemiology, Health Policy, media_common.quotation_subject, Cognition, Mexican americans, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Neurology (clinical), Geriatrics and Gerontology, Worry, Psychology, Clinical psychology, media_common
Published
2018

26. P3‐324: CHARACTERISTICS OF COGNITIVELY NORMAL OLDER MEXICAN AMERICANS AND NON‐HISPANIC WHITES WITH SUBJECTIVE COGNITIVE COMPLAINTS

Author

Melissa Edwards, Leigh A. Johnson, April Wiechmann, Sid E. O'Bryant, and James Hall

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Cognition, Neurology (clinical), Geriatrics and Gerontology, Mexican americans, Psychology, Non-Hispanic whites, Clinical psychology
Published
2018

27. P2‐484: THE IMPACT OF VASCULAR RISK AND DEPRESSION ON EXECUTIVE FUNCTION AMONG MEXICAN AMERICAN WOMEN

Author

Leigh A. Johnson, Haydee Izurieta Munoz, Judith O'Jile, Sid E. O'Bryant, Raul Vintimilla, Stephanie Large, and James Hall

Subjects
Epidemiology, business.industry, Health Policy, Mexican americans, Vascular risk, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Medicine, Neurology (clinical), Geriatrics and Gerontology, business, Depression (differential diagnoses), Clinical psychology
Published
2018

28. P2‐554: CHARACTERIZATION OF WORRY AND ITS EFFECT ON COGNITION IN MEXICAN AMERICAN WOMEN

Author

Judith O'Jile, Sid E. O'Bryant, James Hall, Leigh A. Johnson, and Stephanie Large

Subjects
Epidemiology, Health Policy, media_common.quotation_subject, Cognition, Mexican americans, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Neurology (clinical), Geriatrics and Gerontology, Worry, Psychology, Clinical psychology, media_common
Published
2018

29. P1-543: ETHNIC DIFFERENCES IN RECRUITMENT OF OLDER ADULTS INTO AGING RESEARCH

Author

Leigh A. Johnson, Stephanie Large, Lillian Wong, Haydee Izurieta Munoz, Daisy Ruiz, Sid E. O'Bryant, and James Hall

Subjects
Gerontology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, business.industry, Health Policy, Ethnic group, Medicine, Neurology (clinical), Geriatrics and Gerontology, business
Published
2019

30. P1-262: AUTOMATED DIAGNOSTIC TESTING FOR DETECTION OF ALZHEIMER'S DISEASE

Author

David Julovich, Tori Conger, Sid E. O'Bryant, and James Hall

Subjects
medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Diagnostic test, Disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, medicine, Neurology (clinical), Geriatrics and Gerontology, Intensive care medicine, business
Published
2019

32. [P3–305]: THE RELATIONSHIP BETWEEN SUBJECTIVE MEMORY COMPLAINTS AND AFFECTIVE SYMPTOMS IN MEXICAN AMERICANS WITH MILD COGNITIVE IMPAIRMENT

Author

Leigh A. Johnson, Judith Rosemary O'Jile, Stephanie Large, James Hall, and Sid E. O'Bryant

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Neurology (clinical), Subjective memory, Geriatrics and Gerontology, Mexican americans, Cognitive impairment, Psychology, Developmental psychology, Clinical psychology
Published
2017

33. [P3–234]: THE RELATIONSHIP OF METABOLIC AND INFLAMMATORY BIOMARKERS TO SUBJECTIVE COGNITIVE COMPLAINTS IN A SAMPLE OF COGNITIVELY NORMAL MEXICAN‐AMERICANS

Author

April Wiechmann, Sid E. O'Bryant, James Hall, Melissa Edwards, and Leigh A. Johnson

Subjects
Epidemiology, business.industry, Health Policy, Cognition, Sample (statistics), Mexican americans, Inflammatory biomarkers, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Medicine, Neurology (clinical), Geriatrics and Gerontology, business, Clinical psychology
Published
2017

34. [P4–136]: IL‐10 AND IL‐12/23P40 ARE JOINTLY ASSOCIATED AS PREDICTORS OF Aβ‐AMYLOID LOAD IN A BROADER BLOOD‐BASED BIOMARKER PANEL

Author

Colin L. Masters, James D. Doecke, Eugene Hone, Veer Bala Gupta, Victor L. Villemagne, David Ames, Steve Pedrini, Ian James, Christopher C. Rowe, Ralph N. Martins, Ashley I. Bush, and Sid E. O'Bryant

Subjects
Epidemiology, Blood based biomarkers, business.industry, Health Policy, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Interleukin 10, Developmental Neuroscience, Immunology, Interleukin 12, Medicine, Aβ amyloid, Neurology (clinical), Geriatrics and Gerontology, business
Published
2017

35. Innovative diagnostic tools for early detection of Alzheimer's disease

Author

Peter Garrard, Justin Dauwels, Yogesan Kanagasingam, Ralph N. Martins, Massimo Buscema, Stephanie A. Bridenbaugh, Stephan Mueller, Hamid R. Sohrabi, Shaun Frost, Sid E. O'Bryant, Surjo R. Soekadar, Karmele López-de-Ipiña, Christoph Linnemann, and Christoph Laske

Subjects
medicine.medical_specialty, etiology [Depression], Epidemiology, physiology [Gait], Disease, Eye, methods [Diagnostic Tests, Routine], Cellular and Molecular Neuroscience, blood [Alzheimer Disease], Developmental Neuroscience, Neuroimaging, Alzheimer Disease, medicine, Humans, Dementia, ddc:610, Neuropsychological assessment, Intensive care medicine, Psychiatry, Gait, Neurophysiological Monitoring, Memory Disorders, medicine.diagnostic_test, Depression, Diagnostic Tests, Routine, business.industry, Health Policy, diagnosis [Alzheimer Disease], complications [Alzheimer Disease], Neuropsychological test, medicine.disease, etiology [Memory Disorders], 3. Good health, Electrophysiology, Clinical trial, Psychiatry and Mental health, Early Diagnosis, standards [Diagnostic Tests, Routine], Neurology (clinical), Geriatrics and Gerontology, Alzheimer's disease, physiopathology [Eye], business
Abstract

Current state-of-the-art diagnostic measures of Alzheimer's disease (AD) are invasive (cerebrospinal fluid analysis), expensive (neuroimaging) and time-consuming (neuropsychological assessment) and thus have limited accessibility as frontline screening and diagnostic tools for AD. Thus, there is an increasing need for additional noninvasive and/or cost-effective tools, allowing identification of subjects in the preclinical or early clinical stages of AD who could be suitable for further cognitive evaluation and dementia diagnostics. Implementation of such tests may facilitate early and potentially more effective therapeutic and preventative strategies for AD. Before applying them in clinical practice, these tools should be examined in ongoing large clinical trials. This review will summarize and highlight the most promising screening tools including neuropsychometric, clinical, blood, and neurophysiological tests.

Published
2014

37. P4-373: IMPACT OF PHYSICAL ACTIVITY ON COGNITION IN OLDER MEXICAN AMERICANS WITH DIABETES

Author

Stephanie Large, Judith Rosemary O'Jile, Kamiah Moss, Sid E. O'Bryant, Leigh A. Johnson, and James Hall

Subjects
Gerontology, Epidemiology, Health Policy, Physical activity, Cognition, Mexican americans, medicine.disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Diabetes mellitus, medicine, Neurology (clinical), Geriatrics and Gerontology, Psychology
Published
2019

38. The future of blood‐based biomarkers for Alzheimer's disease

Author

Kim, Henriksen, Sid E, O'Bryant, Harald, Hampel, John Q, Trojanowski, Thomas J, Montine, Andreas, Jeromin, Kaj, Blennow, Anders, Lönneborg, Tony, Wyss-Coray, Holly, Soares, Chantal, Bazenet, Magnus, Sjögren, William, Hu, Simon, Lovestone, Morten A, Karsdal, Michael W, Weiner, and Hugo, Vanderstiechele

Subjects
medicine.medical_specialty, Epidemiology, Disease, Article, Cellular and Molecular Neuroscience, Developmental Neuroscience, Alzheimer Disease, medicine, Humans, Biomarker discovery, Intensive care medicine, Blood based biomarkers, business.industry, Health Policy, Disease progression, medicine.disease, Psychiatry and Mental health, Interest group, Immunology, Disease Progression, Disease risk, Biomarker (medicine), Neurology (clinical), Geriatrics and Gerontology, Alzheimer's disease, business, Biomarkers
Abstract

Treatment of Alzheimer's disease (AD) is significantly hampered by the lack of easily accessible biomarkers that can detect disease presence and predict disease risk reliably. Fluid biomarkers of AD currently provide indications of disease stage; however, they are not robust predictors of disease progression or treatment response, and most are measured in cerebrospinal fluid, which limits their applicability. With these aspects in mind, the aim of this article is to underscore the concerted efforts of the Blood-Based Biomarker Interest Group, an international working group of experts in the field. The points addressed include: (1) the major challenges in the development of blood-based biomarkers of AD, including patient heterogeneity, inclusion of the "right" control population, and the blood–brain barrier; (2) the need for a clear definition of the purpose of the individual markers (e.g., prognostic, diagnostic, or monitoring therapeutic efficacy); (3) a critical evaluation of the ongoing biomarker approaches; and (4) highlighting the need for standardization of preanalytical variables and analytical methodologies used by the field.

Published
2013

39. P3‐326: The Relationship of Subjective Cognitive Concerns and Cognitive Functioning in a Sample of Cognitively Normal Mexican‐American Adults

Author

Leigh A. Johnson, Adriana Gamboa, Melissa Edwards, April Wiechmann, James Hall, and Sid E. O'Bryant

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Cognition, Sample (statistics), Neurology (clinical), Cognitive skill, Geriatrics and Gerontology, Mexican americans, Psychology, Clinical psychology
Published
2016

40. P3‐176: Biomarkers of a Depressive Endophenotype

Author

Sid E. O'Bryant, Stephanie Large, James Hall, Melissa Edwards, Long Wong M.D. Ph.D, Adriana Gamboa, Brent L. Weiser, Raul Vintimilla, and Leigh A. Johnson

Subjects
Oncology, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Internal medicine, Endophenotype, medicine, Neurology (clinical), Geriatrics and Gerontology, business
Published
2016

41. P3‐149: Diagnosis of Diabetes Mellitus Does Not Differentially Impact the Proteomic Profile of Mild Cognitive Impairment Among Mexican Americans

Author

James Hall, Sid E. O'Bryant, Melissa Edwards, and Leigh A. Johnson

Subjects
Gerontology, Proteomic Profile, Epidemiology, business.industry, Health Policy, Mexican americans, medicine.disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Diabetes mellitus, medicine, Neurology (clinical), Geriatrics and Gerontology, business, Cognitive impairment
Published
2016

42. S5‐01‐02: Blood biomarker assays

Author

Sid E. O'Bryant

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, business.industry, Health Policy, Cancer research, Biomarker (medicine), Medicine, Neurology (clinical), Geriatrics and Gerontology, business
Published
2015

43. P3‐124: A depressive endophenotype for predicting cognitive decline among mexican american adults and elders

Author

Leigh A. Johnson, James Hall, Sid E. O'Bryant, Adriana Gamboa Guzman, Amy Moss, Melissa Edwards, Raul Vintimilla, and Janice Knebl

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Endophenotype, Neurology (clinical), Geriatrics and Gerontology, Mexican americans, Cognitive decline, Psychology, Clinical psychology
Published
2015

44. P1‐037: GENOME‐WIDE ASSOCIATION SCAN OF ALZHEIMER'S DISEASE ENDOPHENOTYPES

Author

Shantanu J. Shewale, Jeffrey L. Tilson, Jessica L. Koenig, Nicole Phillips, Sid E. O'Bryant, Ramon Diaz-Arrastia, Ryan M. Huebinger, Kirk C. Wilhelmsen, Robert Barber, Rhonda K. Roby, and Jeffrey S. Mitchel

Subjects
Genome Wide Association Scan, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Endophenotype, Neurology (clinical), Disease, Computational biology, Geriatrics and Gerontology, Biology
Published
2014

45. P1‐131: ALZHEIMER'S DISEASE AND PARKINSON's DISEASE: BLOOD BIOMARKER DIFFERENCES

Author

Padraig E. O'Suilleabhain, Fan Zhang, Dwight C. German, and Sid E. O'Bryant

Subjects
Oncology, medicine.medical_specialty, Parkinson's disease, Epidemiology, business.industry, Health Policy, Disease, medicine.disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Internal medicine, Medicine, Biomarker (medicine), Neurology (clinical), Geriatrics and Gerontology, business
Published
2014

46. P3‐086: APOE4 GENOTYPE IMPACTS ACCURACY OF BLOOD ALGORITHM FOR DISTINGUISHING MCI FROM AD

Author

Melissa Edwards, Ryan M. Huebinger, Munro Cullum, Roger N. Rosenberg, Janet Smith, Linda S. Hynan, Joan S. Reisch, Laura H. Lacritz, Ellen Suen, and Sid E. O'Bryant

Subjects
Oncology, medicine.medical_specialty, Pathology, Epidemiology, Health Policy, Biology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Internal medicine, Genotype, medicine, Neurology (clinical), Geriatrics and Gerontology
Published
2014

47. P3‐081: GLP‐1 AND DELAYED MEMORY PERFORMANCE AMONG MILD COGNITIVE IMPAIRMENT CASES WITH AND WITHOUT DIABETES MELLITUS

Author

Robert Barber, Melissa Edwards, Sid E. O'Bryant, and James Hall

Subjects
Pediatrics, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, medicine.disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Diabetes mellitus, medicine, Delayed Memory, Neurology (clinical), Geriatrics and Gerontology, business, Cognitive impairment
Published
2014

48. F5‐02‐04: BLOOD‐BASED BIOMARKERS OF NEUROPSYCHIATRIC SYMPTOMS IN ALZHEIMER'S: INFLAMMATION, VASCULAR RISKS, GENDER, AND APOE‐E4 STATUS

Author

James Hall, April Wiechmann, Robert Barber, Sid E. O'Bryant, Leigh A. Johnson, and Melissa Edwards

Subjects
Pathology, medicine.medical_specialty, Epidemiology, business.industry, Blood based biomarkers, Health Policy, Inflammation, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Immunology, medicine, Neurology (clinical), Geriatrics and Gerontology, medicine.symptom, business
Published
2014

49. O4‐11‐03: A PROINFLAMMATORY ENDOPHENOTYPE PREDICTS TREATMENT RESPONSE IN A MULTICENTER TRIAL OF NSAIDS IN AD

Author

Sid E. O'Bryant, Constantine G. Lyketsos, and Robert A. Rissman

Subjects
Oncology, medicine.medical_specialty, Treatment response, Epidemiology, business.industry, Health Policy, Proinflammatory cytokine, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Internal medicine, Endophenotype, Multicenter trial, medicine, Neurology (clinical), Geriatrics and Gerontology, business
Published
2014

50. P1–232: Validation of a serum‐based screen for Alzheimer's disease

Author

Tori Como, Sid E. O'Bryant, Guanghua Xiao, Melissa Edwards, James Hall, Padraig E. O'Suilleabhain, Dwight C. German, Benjamin Williams, Robert Barber, and Fan Zhang

Subjects
Oncology, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Internal medicine, medicine, Neurology (clinical), Geriatrics and Gerontology, business
Published
2013

Catalog

Books, media, physical & digital resources
See catalog results